Virax Biolabs
VRAX
VRAX
4 hedge funds and large institutions have $71.5K invested in Virax Biolabs in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
-3
Holders Change %
-42.86%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
TSS
Two Sigma Securities
New York
|
+$15.5K |
2 |
Citadel Advisors
Miami,
Florida
|
+$15.4K |
3 |
HF
HRT Financial
New York
|
+$15K |
Top Sellers
1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$26.7K |
2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$23K |
3 |
UBS Group
Zurich,
Switzerland
|
-$17.7K |
4 |
RS
R Squared
Central,
Hong Kong
|
-$6.08K |
5 |
Morgan Stanley
New York
|
-$225 |